<!DOCTYPE html>
<html>
<head>
  <title>511-2018-11-09-depression</title>

  <meta charset="utf-8">
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="X-UA-Compatible" content="chrome=1">
  <meta name="generator" content="pandoc" />




  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta name="apple-mobile-web-app-capable" content="yes">

  <base target="_blank">

  <script type="text/javascript">
    var SLIDE_CONFIG = {
      // Slide settings
      settings: {
                title: '511-2018-11-09-depression',
                        useBuilds: true,
        usePrettify: true,
        enableSlideAreas: true,
        enableTouch: true,
                      },

      // Author information
      presenters: [
            {
        name:  'Rick Gilmore' ,
        company: '',
        gplus: '',
        twitter: '',
        www: '',
        github: ''
      },
            ]
    };
  </script>

  <link href="libs/ioslides-13.5.1/fonts/fonts.css" rel="stylesheet" />
  <link href="libs/ioslides-13.5.1/theme/css/default.css" rel="stylesheet" />
  <link href="libs/ioslides-13.5.1/theme/css/phone.css" rel="stylesheet" />
  <script src="libs/ioslides-13.5.1/js/modernizr.custom.45394.js"></script>
  <script src="libs/ioslides-13.5.1/js/prettify/prettify.js"></script>
  <script src="libs/ioslides-13.5.1/js/prettify/lang-r.js"></script>
  <script src="libs/ioslides-13.5.1/js/prettify/lang-yaml.js"></script>
  <script src="libs/ioslides-13.5.1/js/hammer.js"></script>
  <script src="libs/ioslides-13.5.1/js/slide-controller.js"></script>
  <script src="libs/ioslides-13.5.1/js/slide-deck.js"></script>

  <style type="text/css">

    b, strong {
      font-weight: bold;
    }

    em {
      font-style: italic;
    }

    slides > slide {
      -webkit-transition: all 0.4s ease-in-out;
      -moz-transition: all 0.4s ease-in-out;
      -o-transition: all 0.4s ease-in-out;
      transition: all 0.4s ease-in-out;
    }

    .auto-fadein {
      -webkit-transition: opacity 0.6s ease-in;
      -webkit-transition-delay: 0.4s;
      -moz-transition: opacity 0.6s ease-in 0.4s;
      -o-transition: opacity 0.6s ease-in 0.4s;
      transition: opacity 0.6s ease-in 0.4s;
      opacity: 0;
    }

  </style>

  <link rel="stylesheet" href="css/ioslides.css" type="text/css" />

</head>

<body style="opacity: 0">

<slides class="layout-widescreen">

  <slide class="title-slide segue nobackground">
        <!-- The content of this hgroup is replaced programmatically through the slide_config.json. -->
    <hgroup class="auto-fadein">
      <h1 data-config-title><!-- populated from slide_config.json --></h1>
      <h2 data-config-subtitle><!-- populated from slide_config.json --></h2>
      <p data-config-presenter><!-- populated from slide_config.json --></p>
            <p style="margin-top: 6px; margin-left: -2px;">2018-11-08 16:27:54</p>
          </hgroup>
  </slide>

<slide class=""><hgroup><h2>Today&#39;s topic(s)</h2></hgroup><article  id="todays-topics">

<ul>
<li>Depression</li>
<li>Planning for student-led presentations</li>
</ul>

</article></slide><slide class=""><hgroup><h2>Depression</h2></hgroup><article  id="depression">

<ul>
<li>Symptoms

<ul>
<li>Unhappy mood, insomnia, lethargy, loss of pleasure, interest, energy</li>
</ul></li>
<li>Agitation</li>
<li>Lasting for several weeks or more</li>
</ul>

</article></slide><slide class=""><hgroup><h2>Depression</h2></hgroup><article  id="depression-1">

<ul>
<li>Experienced by ~7% Americans in any year</li>
<li>Prevalence (up to ~20% lifetime)</li>
<li>Females 2-3x males, higher 40+ years of age

<ul>
<li>postpartum anxiety and depression in 10-20% of mothers</li>
</ul></li>
<li>MZ concordance ~60% vs. DZ ~20% suggests genetic component</li>
</ul>

</article></slide><slide class=""><hgroup><h2>Symptoms, <a href='http://doi.org/10.1016/j.neubiorev.2013.11.009' title=''><span class="cite">(Mahar, Bambico, Mechawar, &amp; Nobrega, 2014)</span></a></h2></hgroup><article  id="symptoms-mahar_stress_2014">

<div class="centered">
<p><a href="img/mahar-table-1.jpg"> <img src="img/mahar-table-1.jpg" height=500px> </a></p></div>

</article></slide><slide class=""><hgroup><h2>Neurobiology of Major Depressive Disorder (MDD)</h2></hgroup><article  id="neurobiology-of-major-depressive-disorder-mdd">

<ul>
<li>Reduced sizes of brain regions</li>
<li>Hypoactivity</li>
<li>Pharmacological factors</li>
<li>Synaptic neurotrophic dysfunction</li>
</ul>

</article></slide><slide class=""><hgroup><h2>Neurological factors</h2></hgroup><article  id="neurological-factors">

<ul>
<li>Reduced hippocampal volumes</li>
<li><a href='http://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.161.11.1957' title=''><span class="cite">(Videbech &amp; Ravnkilde, 2004a)</span></a> meta-analysis</li>
</ul>

</article></slide><slide class=""><hgroup><h2><a href='http://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.161.11.1957' title=''><span class="cite">(Videbech &amp; Ravnkilde, 2004a)</span></a></h2></hgroup><article  id="videbech2004-sm">

<div class="centered">
<p>Left Hippocampus</p>

<p><img src="img/videbech-left-hipp.jpg" height=450px></p></div>

</article></slide><slide class=""><hgroup><h2><a href='http://dx.doi.org/10.1176/appi.ajp.161.11.1957' title=''><span class="cite">(Videbech &amp; Ravnkilde, 2004b)</span></a></h2></hgroup><article  id="videbech2004hippocampal">

<div class="centered">
<p>Right Hippocampus</p>

<p><img src="img/videbech-right-hipp.jpg" height=450px></p></div>

</article></slide><slide class=""><hgroup><h2></h2></hgroup><article >

<div class="centered">
<p><img src="img/palazido-2012-table-1.jpg" height=500px/></p>

<p><a href='http://dx.doi.org/10.1093/bmb/lds004' title=''><span class="cite">(Palazidou, 2012)</span></a></p></div>

<!-- Areas of the brain whose sizes are altered in depression -->

</article></slide><slide class=""><hgroup><h2>Hypoactivity in</h2></hgroup><article  id="hypoactivity-in">

<ul>
<li>Frontal and temporal cortex</li>
<li>Anterior cingulate</li>
<li>Insula</li>
<li>Cerebellum</li>
<li><a href='http://dx.doi.org/10.1002/hbm.20426' title=''><span class="cite">(Fitzgerald, Laird, Maller, &amp; Daskalakis, 2008)</span></a></li>
</ul>

</article></slide><slide class=""><hgroup><h2><a href='http://dx.doi.org/10.1002/hbm.20426' title=''><span class="cite">(Fitzgerald et al., 2008)</span></a></h2></hgroup><article  id="fitzgerald_meta-analytic_2008" class="smaller">

<div class="centered">
<p><img src="img/fitzgerald-2008.jpg" height=400px></p>

<p>[a] patients v. ctrls, [b] patients on SSRIs, [c] patients v. ctrls (happy stim), [d] patients v. controls (sad stim)</p></div>

</article></slide><slide class=""><hgroup><h2>Baseline hyperactivity <a href='https://doi.org/10.1176/appi.ajp.2012.11071105' title=''><span class="cite">(Hamilton et al., 2012)</span></a></h2></hgroup><article  id="baseline-hyperactivity-hamilton2012-iv">

<div class="centered">
<p><a href="https://doi.org/10.1176/appi.ajp.2012.11071105"> <img src="http://ajp.psychiatryonline.org/na101/home/literatum/publisher/app/journals/content/ajp/2012/ajp.2012.169.issue-7/appi.ajp.2012.11071105/production/images/large/ajp.169.7.693.f001.jpeg" height=450px> </a></p></div>

</article></slide><slide class=""><hgroup><h2>Valence-specific hyperactivity <a href='https://doi.org/10.1176/appi.ajp.2012.11071105' title=''><span class="cite">(Hamilton et al., 2012)</span></a></h2></hgroup><article  id="valence-specific-hyperactivity-hamilton2012-iv">

<div class="centered">
<p><a href="https://doi.org/10.1176/appi.ajp.2012.11071105"> <img src="http://ajp.psychiatryonline.org/na101/home/literatum/publisher/app/journals/content/ajp/2012/ajp.2012.169.issue-7/appi.ajp.2012.11071105/production/images/large/ajp.169.7.693.f002.jpeg" height=450px> </a></p></div>

</article></slide><slide class=""><hgroup><h2>Increased connectivity between resting state network regions and dorsal PFC <a href='http://doi.org/10.1073/pnas.1000446107' title=''><span class="cite">(Sheline, Price, Yan, &amp; Mintun, 2010)</span></a></h2></hgroup><article  id="increased-connectivity-between-resting-state-network-regions-and-dorsal-pfc-sheline2010-nh" class="smaller">

<div class="centered">
<p><a href="http://doi.org/10.1073/pnas.1000446107"> <img src="http://www.pnas.org/content/107/24/11020/F1.large.jpg" height=400px> </a></p>

<p>CCN (yellow); precuneus, part of DMN (pink); and affective division of the ACC (turquoise)</p></div>

</article></slide><slide class=""><hgroup><h2>Altered connectivity</h2></hgroup><article  id="altered-connectivity">

<p><a href='http://doi.org/10.1093/brain/aww255' title=''><span class="cite">(Cheng et al., 2016)</span></a></p>

<ul>
<li>Resting state fMRI (rsFMRI) in 421 patients with major depressive disorder and 488 control subjects.</li>
<li>Reduced connectivity between orbitofrontal cortex (OFC) and other areas of the brain</li>
<li>Increased connectivity between lateral PFC and other brain areas</li>
</ul>

</article></slide><slide class=""><hgroup><h2></h2></hgroup><article >

<div class="centered">
<p><a href="http://doi.org/10.1093/brain/aww255"> <img src="img/cheng-2016-F1.large-1.jpg" height=500px> </a></p></div>

</article></slide><slide class=""><hgroup><h2></h2></hgroup><article >

<div class="centered">
<p><a href="http://doi.org/10.1093/brain/aww255"> <img src="img/cheng-2016-F2.large-1.jpg" height=500px> </a></p></div>

</article></slide><slide class=""><hgroup><h2></h2></hgroup><article >

<div class="centered">
<p><img src="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/bmb/101/1/10.1093/bmb/lds004/2/m_lds00401.jpeg?Expires=2147483647&Signature=k1Ppd9IqxUhmxtQcyGvxydDeNZSpuLGX9jgNGFy3URlPun5aK2dwxJbyGEGXrXDKdWhBxXxEpzU~mVWqz0B3YC1U4~W10tC0K8r91ynB2r-3lHarpCQnPDZBF2LIP302Mp3VL8MTh9YSQH5EtSmpRjeGOc2OPBC4XPHXdAZl~-5OVz4TtSJNBhXfHoSqabwtN9xHAJJAVkJ7kxpZp3vfVc8JK71NEcBauD7ZM40WtnsIfSIFHc~UvSECc-mbSIJAb1zmbom9U-80FG9NfEc0DbO-xJQTowuJqZD2fig~tlMFCATL8Wk8NwY4ushk~K99gQCJnYpq-~wQbtSacPBzOQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" height=500px/></p>

<p><a href='http://dx.doi.org/10.1093/bmb/lds004' title=''><span class="cite">(Palazidou, 2012)</span></a></p></div>

<!-- Summary of brain areas implicated in depression -->

</article></slide><slide class=""><hgroup><h2>Pharmacological factors</h2></hgroup><article  id="pharmacological-factors">

<ul>
<li>Endocrine

<ul>
<li>Thyroid dysfunction <a href='http://dx.doi.org/10.1210/jc.2013-3589' title=''><span class="cite">(Medici et al., 2014)</span></a></li>
<li>Altered cortisol reactivity <a href='http://dx.doi.org/10.1016/j.psyneuen.2005.02.010' title=''><span class="cite">(Burke, Davis, Otte, &amp; Mohr, 2005)</span></a></li>
</ul></li>
</ul>

</article></slide><slide class=""><hgroup><h2>Pharmacological factors</h2></hgroup><article  id="pharmacological-factors-1">

<ul>
<li>Monoamine hypothesis

<ul>
<li>More: euphoria</li>
<li>Less: depression</li>
<li>Resperine (antagonist for NE &amp; 5-HT) can cause depression</li>
<li>Low serotonin (5-HT) metabolite levels in CSF of suicidal depressives <a href='http://dx.doi.org/10.1111/j.1600-0447.2005.00639.x' title=''><span class="cite">(Samuelsson, Jokinen, Nordström, &amp; Nordström, 2006)</span></a></li>
</ul></li>
</ul>

</article></slide><slide class=""><hgroup><h2>Measuring 5-HT</h2></hgroup><article  id="measuring-5-ht">

<ul>
<li>CSF, platelets, plasma, urine, saliva</li>
<li>CSF &amp; platelets correlate highly <a href='http://dx.doi.org/10.1016/j.bbagen.2012.05.012' title=''><span class="cite">(Audhya, Adams, &amp; Johansen, 2012)</span></a></li>
<li>Salivary 5-HT does not correlate with mood symptoms <a href='http://dx.doi.org/10.1016/j.ymgmr.2018.03.008' title=''><span class="cite">(Leung et al., 2018)</span></a></li>
</ul>

</article></slide><slide class=""><hgroup><h2></h2></hgroup><article >

<div class="centered">
<p><img src="img/palazido-2012-table-2.jpg" height=500px/></p>

<p><a href='http://dx.doi.org/10.1093/bmb/lds004' title=''><span class="cite">(Palazidou, 2012)</span></a></p></div>

<!-- Neurochemical and hormonal alterations in depression -->

</article></slide><slide class=""><hgroup><h2>Drug treatments</h2></hgroup><article  id="drug-treatments">

<ul>
<li>Monoamine oxidase (MAO) inhibitors

<ul>
<li>MAO inactivates monoamines in terminal buttons</li>
<li>MAO-I’s boost monoamine levels</li>
</ul></li>
<li>Tricyclics

<ul>
<li>Inhibit NE, 5-HT reuptake</li>
<li>Upregulate monoamine levels, but non-selective = side effects</li>
</ul></li>
</ul>

</article></slide><slide class=""><hgroup><h2>Drug treatments</h2></hgroup><article  id="drug-treatments-1">

<ul>
<li>Selective Serotonin Reuptake Inhibitors (SSRIs)

<ul>
<li>Fluoxetine (Prozac, Paxil, Zoloft)</li>
<li>Prolong duration 5-HT in synaptic cleft</li>
<li>Also increase brain steroid production</li>
</ul></li>
<li>Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs)</li>
</ul>

</article></slide><slide class=""><hgroup><h2>Cymbalta (SNRI)</h2></hgroup><article  id="cymbalta-snri">

<iframe width="420" height="315" src="https://www.youtube.com/embed/OTZvnAF7UsA" frameborder="0" allowfullscreen>

</iframe>

</article></slide><slide class=""><hgroup><h2>How well do drugs work?</h2></hgroup><article  id="how-well-do-drugs-work">

<ul>
<li><a href='http://www.nimh.nih.gov/funding/clinical-research/practical/stard/allmedicationlevels.shtml' title=''>STAR*D trial</a></li>
<li>On SSRI for 12-14 weeks. ~1/3 achieved remission; 10-15% showed symptom reduction.</li>
<li>If SSRI didn&#39;t work, could switch drugs. ~25% became symptom free.</li>
<li>16% of participants dropped out due to tolerability issues</li>
<li>Took 6-7 weeks to show response.</li>
</ul>

</article></slide><slide class=""><hgroup><h2>Who benefits from drug therapy?</h2></hgroup><article  id="who-benefits-from-drug-therapy">

<ul>
<li>Depends on

<ul>
<li>Early life stress</li>
<li>Brain (amygdala) response to emotional faces <a href='http://doi.org/10.1073/pnas.1606671113' title=''><span class="cite">(Goldstein-Piekarski et al., 2016)</span></a></li>
</ul></li>
<li>Low-stress + low amyg reactivity -&gt; &gt; responding</li>
<li>High stress + high amyg reactivity -&gt; &gt; responding</li>
</ul>

</article></slide><slide class=""><hgroup><h2></h2></hgroup><article >

<div class="centered">
<p><img src="http://www.pnas.org/content/113/42/11955/F2.medium.gif" height=450px></p>

<p><a href='http://doi.org/10.1073/pnas.1606671113' title=''><span class="cite">(Goldstein-Piekarski et al., 2016)</span></a></p></div>

</article></slide><slide class=""><hgroup><h2>Problems with monoamine hypothesis</h2></hgroup><article  id="problems-with-monoamine-hypothesis">

<ul>
<li>Too simplistic</li>
<li>NE, 5-HT interact</li>
<li>Drugs fast acting (min), but improvement slow (weeks)</li>
<li>&quot;No correlation between serotonin and its metabolite 5-HIAA in the cerebrospinal fluid and [11C]AZ10419369 binding measured with PET in healthy volunteers&quot;. <a href='http://hdl.handle.net/10616/44513' title=''><span class="cite">(Tiger et al., 2015)</span></a></li>
</ul>

</article></slide><slide class=""><hgroup><h2></h2></hgroup><article >

<div class="centered">
<blockquote>
<p>&quot;<em>&#8230;we performed the first meta-analysis of the mood effects in ATD and APTD studies. The depletion of monoamine systems (both 5-HT and NE/DA) does not decrease mood in healthy controls. However, in healthy controls with a family history of MDD the results suggest that mood is slightly decreased&#8230;by [monoamine depletion]&#8230;</em>&quot;</p>
</blockquote>

<p><a href='http://dx.doi.org/10.1038/sj.mp.4001949' title=''><span class="cite">(Ruhé, Mason, &amp; Schene, 2007)</span></a></p></div>

</article></slide><slide class=""><hgroup><h2>What do drugs do, then?</h2></hgroup><article  id="what-do-drugs-do-then">

</article></slide><slide class=""><hgroup><h2>Ketamine again</h2></hgroup><article  id="ketamine-again">

<ul>
<li>Relieves depressive symptoms relatively quickly <a href='https://www.ncbi.nlm.nih.gov/pubmed/10686270' title=''><span class="cite">(Berman et al., 2000)</span></a> and <a href='http://dx.doi.org/10.1001/archpsyc.63.8.856' title=''><span class="cite">(Zarate et al., 2006)</span></a></li>
<li>Boosts synaptic spine formation <a href='http://dx.doi.org/10.1126/science.1190287' title=''><span class="cite">(N. Li et al., 2010)</span></a> and reverses effects of induced stress</li>
</ul>

</article></slide><slide class=""><hgroup><h2>Pathway of pathology <a href='http://dx.doi.org/10.1126/science.1222939' title=''><span class="cite">(Duman &amp; Aghajanian, 2012)</span></a></h2></hgroup><article  id="pathway-of-pathology-duman2012-md">

<ul>
<li>Depression ~ chronic stress <a href='http://doi.org/10.1016/j.neubiorev.2013.11.009' title=''><span class="cite">(Mahar et al., 2014)</span></a></li>
<li>Stress -&gt; chronic HPA axis activity</li>
<li>Chronic HPA activity -&gt; neuronal atrophy in hipp &amp; PFC</li>
<li>Stress &amp; cortisol decrease expression of brain-derived neurotrophic factor (BDNF)</li>
<li>BDNF boosts neurogenesis</li>
<li>SSRIs act via BDNF, as do NMDA receptor antagonists (e.g., ketamine)</li>
</ul>

</article></slide><slide class=""><hgroup><h2><a href='http://dx.doi.org/10.1016/j.tins.2011.11.004' title=''><span class="cite">(Duman &amp; Voleti, 2012)</span></a></h2></hgroup><article  id="duman2012-nz">

<div class="centered">
<p><a href="http://dx.doi.org/10.1016/j.tins.2011.11.004"> <img src="https://ars.els-cdn.com/content/image/1-s2.0-S0166223611001913-gr1.jpg" height=450px> </a></p></div>

</article></slide><slide class=""><hgroup><h2><a href='http://dx.doi.org/10.1177/0269881113512909' title=''><span class="cite">(Frohlich &amp; Van Horn, 2014)</span></a></h2></hgroup><article  id="frohlich2014-tq">

<div class="centered">
<p><a href="http://dx.doi.org/10.1177/0269881113512909"> <img src="http://journals.sagepub.com/na101/home/literatum/publisher/sage/journals/content/jopa/2014/jopa_28_4/0269881113512909/20161119/images/medium/10.1177_0269881113512909-fig3.gif" height=450px> </a></p></div>

</article></slide><slide class=""><hgroup><h2>Electroconvulsive Therapy (ECT)</h2></hgroup><article  id="electroconvulsive-therapy-ect">

<ul>
<li>Last line of treatment for drug-resistant depression</li>
<li>Electric current delivered to the brain causes 30-60s seizure.</li>
<li>ECT usually done in a hospital&#39;s operating or recovery room under general anesthesia.</li>
<li>Once every 2 - 5 days for a total of 6 - 12 sessions.</li>
</ul>

</article></slide><slide class=""><hgroup><h2>Electroconvulsive Therapy (ECT)</h2></hgroup><article  id="electroconvulsive-therapy-ect-1">

<ul>
<li>Remission rates of up to 50.9% <a href='http://doi.org/10.1111/j.1399-5618.2012.00997.x' title=''><span class="cite">(Dierckx, Heijnen, Broek, &amp; Birkenhäger, 2012)</span></a></li>
<li>Seems to work via

<ul>
<li>Anticonvulsant (block Na+ channel or enhance GABA function) effects</li>
<li>Neurotrophic (stimulates neurogenesis) effects</li>
</ul></li>
</ul>

</article></slide><slide class=""><hgroup><h2>Putting the pieces together</h2></hgroup><article  id="putting-the-pieces-together">

<div class="centered">
<p><img src="https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/bmb/101/1/10.1093/bmb/lds004/2/m_lds00402.jpeg?Expires=2147483647&Signature=tNJwe~EQlKXRCwAbbb5n7mHXk9PZM-2dPUr5~D~3Bttal1AEudH3CAbMs8LEbBdmQhS-ZQ4p3czOHMtev6lluG-qXIzmW3rAi6lPWIuz4iVuq7XQccT36eCCOOtuBiJjwmVkwVUzr8bxzK3qCxlSZCm6NC1tJOSIJsDpDTwRu7xR27rw28HJ9TzhA7Q47zODf0pSGPK5rG16dHhUgqX57W5Rej8ARNDJE7EvHPcIqXxodn5d9e2JRhGyQyIf4VTBu0CxAlFrv9gkihIgCnjbtMPQwpebUzvcCwYf-~cCJJWDd7H9Dmd-IA7HSMPkxFPVFTNHGC2LC86QlefZKf87WQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" height=500px/></p>

<p><a href='http://dx.doi.org/10.1093/bmb/lds004' title=''><span class="cite">(Palazidou, 2012)</span></a></p></div>

</article></slide><slide class=""><hgroup><h2>The disordered mind: Take home messages</h2></hgroup><article  id="the-disordered-mind-take-home-messages">

<ul>
<li>Multi-level, multi-method, multi-variate approaches essential to understanding mental illness</li>
<li>Developmental processes across the life span</li>
<li>Networks all the way down&#8230;</li>
</ul>

<!-- Scrolling final reference page -->

<!-- http://stackoverflow.com/q/38260799 -->

<style>
slides > slide { overflow: scroll; }
slides > slide:not(.nobackground):before {
  background: none;
  }
slides > slide:not(.nobackground):after {
  content: '';
  background: none;
  }
}
</style>

</article></slide><slide class=""><hgroup><h2>References</h2></hgroup><article  id="references" class="unnumbered smaller">

<div id="refs" class="references">
<div id="ref-Audhya2012-sv">
<p>Audhya, T., Adams, J. B., &amp; Johansen, L. (2012). Correlation of serotonin levels in CSF, platelets, plasma, and urine. <em>Biochimica et Biophysica Acta</em>, <em>1820</em>(10), 1496–1501. <a href='https://doi.org/10.1016/j.bbagen.2012.05.012' title=''>https://doi.org/10.1016/j.bbagen.2012.05.012</a></p></div>

<div id="ref-Berman2000-vg">
<p>Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., &amp; Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. <em>Biol. Psychiatry</em>, <em>47</em>(4), 351–354. Retrieved from <a href='https://www.ncbi.nlm.nih.gov/pubmed/10686270' title=''>https://www.ncbi.nlm.nih.gov/pubmed/10686270</a></p></div>

<div id="ref-Burke2005-ya">
<p>Burke, H. M., Davis, M. C., Otte, C., &amp; Mohr, D. C. (2005). Depression and cortisol responses to psychological stress: A meta-analysis. <em>Psychoneuroendocrinology</em>, <em>30</em>(9), 846–856. <a href='https://doi.org/10.1016/j.psyneuen.2005.02.010' title=''>https://doi.org/10.1016/j.psyneuen.2005.02.010</a></p></div>

<div id="ref-cheng_medial_2016">
<p>Cheng, W., Rolls, E. T., Qiu, J., Liu, W., Tang, Y., Huang, C.-C., … Feng, J. (2016). Medial reward and lateral non-reward orbitofrontal cortex circuits change in opposite directions in depression. <em>Brain</em>, aww255. <a href='https://doi.org/10.1093/brain/aww255' title=''>https://doi.org/10.1093/brain/aww255</a></p></div>

<div id="ref-dierckx_efficacy_2012">
<p>Dierckx, B., Heijnen, W. T., Broek, W. W. van den, &amp; Birkenhäger, T. K. (2012). Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: A meta-analysis. <em>Bipolar Disorders</em>, <em>14</em>(2), 146–150. <a href='https://doi.org/10.1111/j.1399-5618.2012.00997.x' title=''>https://doi.org/10.1111/j.1399-5618.2012.00997.x</a></p></div>

<div id="ref-Duman2012-md">
<p>Duman, R. S., &amp; Aghajanian, G. K. (2012). Synaptic dysfunction in depression: Potential therapeutic targets. <em>Science</em>, <em>338</em>(6103), 68–72. <a href='https://doi.org/10.1126/science.1222939' title=''>https://doi.org/10.1126/science.1222939</a></p></div>

<div id="ref-Duman2012-nz">
<p>Duman, R. S., &amp; Voleti, B. (2012). Signaling pathways underlying the pathophysiology and treatment of depression: Novel mechanisms for rapid-acting agents. <em>Trends Neurosci.</em>, <em>35</em>(1), 47–56. <a href='https://doi.org/10.1016/j.tins.2011.11.004' title=''>https://doi.org/10.1016/j.tins.2011.11.004</a></p></div>

<div id="ref-fitzgerald_meta-analytic_2008">
<p>Fitzgerald, P. B., Laird, A. R., Maller, J., &amp; Daskalakis, Z. J. (2008). A meta-analytic study of changes in brain activation in depression. <em>Human Brain Mapping</em>, <em>29</em>(6), 683–695. <a href='https://doi.org/10.1002/hbm.20426' title=''>https://doi.org/10.1002/hbm.20426</a></p></div>

<div id="ref-Frohlich2014-tq">
<p>Frohlich, J., &amp; Van Horn, J. D. (2014). Reviewing the ketamine model for schizophrenia. <em>J. Psychopharmacol.</em>, <em>28</em>(4), 287–302. <a href='https://doi.org/10.1177/0269881113512909' title=''>https://doi.org/10.1177/0269881113512909</a></p></div>

<div id="ref-goldstein-piekarski_human_2016">
<p>Goldstein-Piekarski, A. N., Korgaonkar, M. S., Green, E., Suppes, T., Schatzberg, A. F., Hastie, T., … Williams, L. M. (2016). Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants. <em>Proceedings of the National Academy of Sciences</em>, <em>113</em>(42), 11955–11960. <a href='https://doi.org/10.1073/pnas.1606671113' title=''>https://doi.org/10.1073/pnas.1606671113</a></p></div>

<div id="ref-Hamilton2012-iv">
<p>Hamilton, J. P., Etkin, A., Furman, D. J., Lemus, M. G., Johnson, R. F., &amp; Gotlib, I. H. (2012). Functional neuroimaging of major depressive disorder: A Meta-Analysis and new integration of baseline activation and neural response data. <em>AJP</em>, <em>169</em>(7), 693–703. <a href='https://doi.org/10.1176/appi.ajp.2012.11071105' title=''>https://doi.org/10.1176/appi.ajp.2012.11071105</a></p></div>

<div id="ref-Leung2018-ks">
<p>Leung, J., Selvage, C., Bosdet, T., Branov, J., Rosen-Heath, A., Bishop, C., … Horvath, G. (2018). Salivary serotonin does not correlate with central serotonin turnover in adult phenylketonuria (PKU) patients. <em>Molecular Genetics and Metabolism Reports</em>, <em>15</em>, 100–105. <a href='https://doi.org/10.1016/j.ymgmr.2018.03.008' title=''>https://doi.org/10.1016/j.ymgmr.2018.03.008</a></p></div>

<div id="ref-Li2010-ve">
<p>Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., … Duman, R. S. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. <em>Science</em>, <em>329</em>(5994), 959–964. <a href='https://doi.org/10.1126/science.1190287' title=''>https://doi.org/10.1126/science.1190287</a></p></div>

<div id="ref-mahar_stress_2014">
<p>Mahar, I., Bambico, F. R., Mechawar, N., &amp; Nobrega, J. N. (2014). Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. <em>Neuroscience &amp; Biobehavioral Reviews</em>, <em>38</em>, 173–192. <a href='https://doi.org/10.1016/j.neubiorev.2013.11.009' title=''>https://doi.org/10.1016/j.neubiorev.2013.11.009</a></p></div>

<div id="ref-Medici2014-pn">
<p>Medici, M., Direk, N., Visser, W. E., Korevaar, T. I. M., Hofman, A., Visser, T. J., … Peeters, R. P. (2014). Thyroid function within the normal range and the risk of depression: A population-based cohort study. <em>J. Clin. Endocrinol. Metab.</em>, <em>99</em>(4), 1213–1219. <a href='https://doi.org/10.1210/jc.2013-3589' title=''>https://doi.org/10.1210/jc.2013-3589</a></p></div>

<div id="ref-Palazidou2012-je">
<p>Palazidou, E. (2012). The neurobiology of depression. <em>British Medical Bulletin</em>, <em>101</em>, 127–145. <a href='https://doi.org/10.1093/bmb/lds004' title=''>https://doi.org/10.1093/bmb/lds004</a></p></div>

<div id="ref-Ruhe2007-qc">
<p>Ruhé, H. G., Mason, N. S., &amp; Schene, A. H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. <em>Molecular Psychiatry</em>, <em>12</em>(4), 331–359. <a href='https://doi.org/10.1038/sj.mp.4001949' title=''>https://doi.org/10.1038/sj.mp.4001949</a></p></div>

<div id="ref-samuelsson_csf_2006">
<p>Samuelsson, M., Jokinen, J., Nordström, A.-L., &amp; Nordström, P. (2006). CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. <em>Acta Psychiatrica Scandinavica</em>, <em>113</em>(1), 44–47. <a href='https://doi.org/10.1111/j.1600-0447.2005.00639.x' title=''>https://doi.org/10.1111/j.1600-0447.2005.00639.x</a></p></div>

<div id="ref-Sheline2010-nh">
<p>Sheline, Y. I., Price, J. L., Yan, Z., &amp; Mintun, M. A. (2010). Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. <em>Proc. Natl. Acad. Sci. U. S. A.</em>, <em>107</em>(24), 11020–11025. <a href='https://doi.org/10.1073/pnas.1000446107' title=''>https://doi.org/10.1073/pnas.1000446107</a></p></div>

<div id="ref-Tiger2015-dy">
<p>Tiger, M., Svenningsson, P., Nord, M., Jabre, S., Halldin, C., &amp; Lundberg, J. (2015). No correlation between serotonin and its metabolite 5-HIAA in the cerebrospinal fluid and [11C]AZ10419369 binding measured with PET in healthy volunteers. Retrieved from <a href='http://hdl.handle.net/10616/44513' title=''>http://hdl.handle.net/10616/44513</a></p></div>

<div id="ref-Videbech2004-sm">
<p>Videbech, P., &amp; Ravnkilde, B. (2004a). Hippocampal volume and depression: A meta-analysis of MRI studies. <em>Am. J. Psychiatry</em>, <em>161</em>(11), 1957–1966. <a href='https://doi.org/10.1176/appi.ajp.161.11.1957' title=''>https://doi.org/10.1176/appi.ajp.161.11.1957</a></p></div>

<div id="ref-videbech2004hippocampal">
<p>Videbech, P., &amp; Ravnkilde, B. (2004b). Hippocampal volume and depression: A meta-analysis of mri studies. <em>American Journal of Psychiatry</em>, <em>161</em>(11), 1957–1966. <a href='https://doi.org/10.1176/appi.ajp.161.11.1957' title=''>https://doi.org/10.1176/appi.ajp.161.11.1957</a></p></div>

<div id="ref-Zarate2006-np">
<p>Zarate, C. A., Jr, Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., … Manji, H. K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. <em>Arch. Gen. Psychiatry</em>, <em>63</em>(8), 856–864. <a href='https://doi.org/10.1001/archpsyc.63.8.856' title=''>https://doi.org/10.1001/archpsyc.63.8.856</a></p></div></div></article></slide>


  <slide class="backdrop"></slide>

</slides>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

<!-- map slide visiblity events into shiny -->
<script>
  (function() {
    if (window.jQuery) {
       window.jQuery(document).on('slideleave', function(e) {
         window.jQuery(e.target).trigger('hidden');
      });
       window.jQuery(document).on('slideenter', function(e) {
         window.jQuery(e.target).trigger('shown');
      });
    }
  })();
</script>

</body>
</html>
